The vending machines will start to roll out in Los Angeles in December and carry a range of drugs like antibiotics, asthma ...

Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for adults ...

The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the ...

Sanofi raised its interest in AlphaMedix when it bought a 16% stake in Orano Med, a subsidiary of French nuclear fuel company ...

CSL Behring's Andembry can be used to prevent recurrent attacks of hereditary angioedema (HAE) by the NHS, according to ...

A jury in a Los Angeles, California court has ordered the company to pay an eye-watering $966 million to the family of Mae ...

The former director of the FDA's Center for Biologics Evaluation and Research (CBER), Peter Marks, has joined Eli Lilly as ...

As one of Frontiers Health’s most recognisable faces (and voices), Jessica DaMassa, founder of WTF Health and long-time emcee of the conference, has had a front-row seat to the events evolution over ...

On the outskirts of the LSX conference in Boston last month, pharmaphorum editor-in-chief Jonah Comstock sat down with Eron Kelly, CEO of Concert AI, to discuss the work his Boston-based start-up is ...

Earlier this year at the American Society of Clinical Oncology (ASCO) Congress, pharmaphorum spoke with Redwood City, ...

While advances in drug development have accelerated dramatically in recent years, pharmaceutical manufacturing processes have ...

Last year, Idorsia Pharma claimed FDA approval for Tryvio (aprocitentan) as the first endothelin receptor antagonist for ...